Loading the content...
Navigation

No products in the cart.

ACP-105

Return to Previous Page
Description

Description

Sample size: 30ml   |   10mg/ml  |   300mg   |   98% Purity

M.Wt: 290.79 g/mol
Formula: C16H19CIN2O
Solubility: DMSO
Purity: >98%
Storage: at 20℃ 2 years
Half life: –
CAS No.: 899821-23-9

Activity of ACP-105:

ACP-105 was first mentioned in the scientific literature in 2009. [J Med Chem. 2009 Nov 26;52(22):7186-91.] This study showed that a relatively low concentration of ACP-105 attaches itself to the androgen receptor better than DHT does

ACP-105 can be taken orally and may be an effective SARM, according to the results of an animal study that the researchers performed. “The principal finding from this study was that 1 [ACP-105] produced a robust anabolic effect on the levator ani muscle (67% reversal of ORX-induced atrophy at 1 (mg/kg)/day) while having lesser androgenic effects on prostate (21% reversal; T, 48%)”, they wrote.

The equivalent of the dosage mentioned, for a man weighing 80 kg, would be about 11 mg per day.

From animal studies it seems that ACP-105 may offer protection against the effects of nuclear radiation. [Brain Res. 2011 Mar 24;1381:134-40.]


 

*This article is intended for educational / informational purposes only.

 

For bulk purchases, please contact sales@researchsarms.co.uk

For Custom solution orders, please contact info@researchsarms.co.uk

Store at room temperature out of direct light.

This product is for in vitro testing and laboratory experimentation.

1ML applicator is included with each order for your convenience but more can be added to your shopping cart.

Testing Documentation
Full Testing documentation will be uploaded to individual pages soon. To request it prior to this please email us at info@researchsarms.co.uk
Back to top